Avalon GloboCare Competitors

CGI (NYSE:GIB) and Avalon GloboCare (NASDAQ:AVCO) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation.

Earnings and Valuation

This table compares CGI and Avalon GloboCare's top-line revenue, earnings per share (EPS) and valuation.

CGI has higher revenue and earnings than Avalon GloboCare.

Analyst Ratings

This is a summary of current ratings and price targets for CGI and Avalon GloboCare, as provided by MarketBeat.

CGI presently has a consensus target price of $107.95, suggesting a potential upside of 26.78%. Given CGI's higher possible upside, analysts plainly believe CGI is more favorable than Avalon GloboCare.

Institutional and Insider Ownership

51.3% of CGI shares are held by institutional investors. Comparatively, 3.2% of Avalon GloboCare shares are held by institutional investors. 9.9% of CGI shares are held by company insiders. Comparatively, 73.4% of Avalon GloboCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

CGI has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Profitability

This table compares CGI and Avalon GloboCare's net margins, return on equity and return on assets.

Summary

CGI beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Booz Allen Hamilton (NYSE:BAH) and Avalon GloboCare (NASDAQ:AVCO) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

Analyst Ratings

This is a summary of recent ratings and target prices for Booz Allen Hamilton and Avalon GloboCare, as reported by MarketBeat.

Booz Allen Hamilton presently has a consensus target price of $85.2857, suggesting a potential upside of 2.27%. Given Booz Allen Hamilton's higher possible upside, research analysts clearly believe Booz Allen Hamilton is more favorable than Avalon GloboCare.

Profitability

This table compares Booz Allen Hamilton and Avalon GloboCare's net margins, return on equity and return on assets.

Institutional & Insider Ownership

89.9% of Booz Allen Hamilton shares are owned by institutional investors. Comparatively, 3.2% of Avalon GloboCare shares are owned by institutional investors. 2.0% of Booz Allen Hamilton shares are owned by insiders. Comparatively, 73.4% of Avalon GloboCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Booz Allen Hamilton and Avalon GloboCare's revenue, earnings per share (EPS) and valuation.

Booz Allen Hamilton has higher revenue and earnings than Avalon GloboCare.

Risk & Volatility

Booz Allen Hamilton has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500.

Summary

Booz Allen Hamilton beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and Genpact (NYSE:G) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Risk & Volatility

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Genpact has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and Genpact's gross revenue, earnings per share and valuation.

Genpact has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and Genpact's net margins, return on equity and return on assets.

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 97.5% of Genpact shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by company insiders. Comparatively, 1.9% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and Genpact, as reported by MarketBeat.com.

Genpact has a consensus target price of $43.00, indicating a potential downside of 3.85%. Given Genpact's higher probable upside, analysts clearly believe Genpact is more favorable than Avalon GloboCare.

Summary

Genpact beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and Exponent's top-line revenue, earnings per share (EPS) and valuation.

Exponent has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and Exponent's net margins, return on equity and return on assets.

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 90.3% of Exponent shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 2.2% of Exponent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and Exponent, as provided by MarketBeat.com.

Exponent has a consensus target price of $94.00, indicating a potential downside of 3.42%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than Avalon GloboCare.

Summary

Exponent beats Avalon GloboCare on 8 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and FTI Consulting (NYSE:FCN) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and FTI Consulting's top-line revenue, earnings per share (EPS) and valuation.

FTI Consulting has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and FTI Consulting's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and FTI Consulting, as provided by MarketBeat.com.

FTI Consulting has a consensus target price of $167.00, indicating a potential upside of 14.58%. Given FTI Consulting's higher possible upside, analysts clearly believe FTI Consulting is more favorable than Avalon GloboCare.

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 97.3% of FTI Consulting shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 2.2% of FTI Consulting shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

FTI Consulting beats Avalon GloboCare on 8 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and ICF International (NASDAQ:ICFI) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Avalon GloboCare and ICF International, as provided by MarketBeat.

ICF International has a consensus target price of $102.00, indicating a potential upside of 13.37%. Given ICF International's higher possible upside, analysts plainly believe ICF International is more favorable than Avalon GloboCare.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, ICF International has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

Profitability

This table compares Avalon GloboCare and ICF International's net margins, return on equity and return on assets.

Insider & Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 88.3% of ICF International shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 4.3% of ICF International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Avalon GloboCare and ICF International's top-line revenue, earnings per share (EPS) and valuation.

ICF International has higher revenue and earnings than Avalon GloboCare.

Summary

ICF International beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.